Publications 2014 |
DERMATITE ATOPIQUEMengeaud V, Phulpin C, Bacquey A, Boralevi F, Schmitt A, Taieb A. An Innovative Oat-Based Sterile Emollient Cream in the Maintenance Therapy ofChildhood Atopic Dermatitis. Pediatr Dermatol. 2014 Dec 22. doi: 10.1111/pde.12464. [Epub ahead of print] PubMed PMID: 25529232. Taïeb A. Which HOME for atopic dermatitis? Br J Dermatol. 2014Dec;171(6):1286-7. doi: 10.1111/bjd.13448. PubMed PMID: 25523249. Taïeb A, Boralevi F, Seneschal J, Merhand S, Georgescu V, Taieb C, Ezzedine K. Atopic Dermatitis Burden Scale - Adult: Development and Validation of a NewAssessment Tool. Acta Derm Venereol. 2014 Aug 14. doi: 10.2340/00015555-1945. [Epub ahead of print] PubMed PMID: 25118699. Wallach D, Taïeb A. Atopic dermatitis/atopic eczema. Chem Immunol Allergy.2014;100:81-96. doi: 10.1159/000358606. Epub 2014 May 22. PubMed PMID: 24925387. Boralevi F, Saint Aroman M, Delarue A, Raudsepp H, Kaszuba A, Bylaite M, Tiplica GS. Long-term emollient therapy improves xerosis in children with atopic dermatitis. J Eur Acad Dermatol Venereol. 2014 Nov;28(11):1456-62. doi: 10.1111/jdv.12314. Epub 2013 Nov 25. PubMed PMID: 24267728. VITILIGOEzzedine K, Le Thuaut A, Jouary T, Ballanger F, Taieb A, Bastuji-Garin S. Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes. Pigment Cell Melanoma Res. 2014 Jan;27(1):134-9. doi: 10.1111/pcmr.12186. Epub 2013 Nov 13. PubMed PMID: 24127636. Bertolotti A, Boniface K, Vergier B, Mossalayi D, Taieb A, Ezzedine K, Seneschal J. Type I interferon signature in the initiation of the immune response in vitiligo. Pigment Cell Melanoma Res. 2014 May;27(3):398-407. doi: 10.1111/pcmr.12219. Epub 2014 Feb 21. PubMed PMID: 24438589. Cavalié M, Ezzedine K, Fontas E, Montaudié H, Castela E, Bahadoran P, Taïeb A, Lacour J, Passeron T. Maintenance Therapy of Adult Vitiligo With 0.1% Tacrolimus Ointment: A Randomized, Double Blind, Placebo-Controlled Study. J Invest Dermatol. 2014 Dec 18. doi: 10.1038/jid.2014.527. [Epub ahead of print] PubMed PMID: 25521460. Ezzedine K, Mahé A, van Geel N, Cardot-Leccia N, Gauthier Y, Descamps V, Al Issa A, Ly F, Chosidow O, Taïeb A, Passeron T. Hypochromic vitiligo: delineation of a new entity. Br J Dermatol. 2014 Sep 25. doi: 10.1111/bjd.13423. [Epub ahead of print] PubMed PMID: 25255745. Seneschal J, Boniface K, Ezzedine K, Taieb A. Accelerating bleaching in vitiligo: balancing benefits versus risks. Exp Dermatol. 2014 Dec;23(12):879-80. doi: 10.1111/exd.12508. PubMed PMID: 25039467. Ezzedine K, Salzes C, Seneschal J, Taieb A, Taieb C. Le fardeau du vitiligo selon le phototype. Ann Dermatol Venereol. 2014 Jun;141(6-7 Suppl 2):S92. doi: 10.1016/j.annder.2014.04.159. Epub 2014 Jun 2. French. PubMed PMID: 24942441. Marie J, Kovacs D, Pain C, Jouary T, Cota C, Vergier B, Picardo M, Taieb A, Ezzedine K, Cario-André M. Inflammasome activation and vitiligo/nonsegmentalvitiligo progression. Br J Dermatol. 2014 Apr;170(4):816-23. doi: 10.1111/bjd.12691. PubMed PMID: 24734946. PSORIASISMahé E, Beauchet A, Bodemer C, Phan A, Bursztejn AC, Boralevi F, Souillet AL, Chiaverini C, Bourrat E, Miquel J, Vabres P, Barbarot S, Bessis D, Eschard C, Hadj-Rabia S. Psoriasis and obesity in French children: a case-control, multicentre study. Br J Dermatol. 2014 Oct 31. doi: 10.1111/bjd.13507. [Epub ahead of print] PubMed PMID: 25363889. Descamps V, Mahé E, Maccari F, Begon E, Barthelemy H, Reguiai Z, Bénéton N, Estève E, Chaby G, Ruer-Mulard M, Steiner HG, Thomas-Beaulieu D, Avenel-Audran M, Goujon-Henry C, Sigal ML, Ezzedine K, Beauchet A; Groupe d’Etudes Multicentriques RESOPSO. Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years. Eur J Dermatol. 2014 May-Jun;24(3):356-60. doi: 10.1684/ejd.2014.2346. PubMed PMID: 24979347. TOXIDERMIE
Bernardeschi C, Valeyrie-Allanore L, Ortonne N, Gressier L, Wallet-Faber N, Bernard PH, Hezode C, Duclos-Vallée JC, Samuel D, Mallet V, Pol S, Milpied B, Dupin N. Dermatological side-effects in hepatitis C infected patients under a triple regimen associating pegylated interferon, ribavirin and telaprevir. J Eur Acad Dermatol Venereol. 2014 Sep 3. doi: 10.1111/jdv.12635. [Epub ahead of print] PubMed PMID: 25187266. Gey A, Milpied B, Dutriaux C, Mateus C, Robert C, Perro G, Taieb A, Ezzedine K, Jouary T. Severe cutaneous adverse reaction associated with vemurafenib: DRESS, AGEP or overlap reaction? J Eur Acad Dermatol Venereol. 2014 Aug 29. doi: 10.1111/jdv.12685. [Epub ahead of print] PubMed PMID: 25175726. Sibaud V, Boralevi F, Vigarios E, Fricain JC. [Oral toxicity of targeted anticancer therapies]. Ann Dermatol Venereol. 2014 May;141(5):354-63. doi: 10.1016/j.annder.2014.03.009. Epub 2014 Apr 13. French. PubMed PMID: 24835648. MALADIE INFLAMMATOIRE AUTREJouary T, Guillet S, Droitcourt C, Dutriaux C, Ezzedine K, Goussot JF, Taieb A. Lichen sclerosus mimicking halo-naevus comedonicus. J Eur Acad Dermatol Venereol. 2014 Oct 29. doi: 10.1111/jdv.12800. [Epub ahead of print] PubMed PMID: 25354312. Taieb A, Ortonne JP, Ruzicka T, Roszkiewicz J, Berth-Jones J, Peirone MH, Jacovella J; The ivermectin Phase III study group. Superiority of ivermectin 1% cream over metronidazole 0.75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. Br J Dermatol. 2014 Sep 16. doi: 10.1111/bjd.13408. [Epub ahead of print] PubMed PMID: 25228137. Amazan E, Ezzedine K, Mossalayi MD, Taieb A, Boniface K, Seneschal J. Expression of interleukin-1 alpha in amicrobial pustulosis of the skin folds with complete response to anakinra. J Am Acad Dermatol. 2014 Aug;71(2):e53-6. doi: 10.1016/j.jaad.2013.12.041. PubMed PMID: 25037815. Gelot P, Avenel-Audran M, Balica S, Bensefa L, Crépy MN, Debons M, Ammari H, Milpied B, Raison N, Vigan M, Weibel N, Stalder JF, Bernier C; Avec soutien du Groupe d’Éducation Thérapeutique de Société Française de Dermatologie. [Therapeutic patient education in chronic hand dermatitis]. Ann Dermatol Venereol. 2014 Jun;141 Suppl 1:S127-42. doi: 10.1016/S0151-9638(14)70150-4. French. PubMed PMID: 24953622. Tauber M, Buche S, Reygagne P, Berthelot JM, Aubin F, Ghislain PD, Cohen JD, Coquerelle P, Goujon E, Jullien D, Brixi H, Jeudy G, Guennoc X, Martin A, Brénaut E, Hoppé E, Bertolotti A, Bardin T, Delaporte E, Allez M, Bachelez H, Seneschal J, Viguier M; Groupe de Recherche sur Psoriasis de Société Française de Dermatologie; Club Rhumatismes et Inflammation (CRI); Groupe d'études thérapeutiques des affections inflammatoires du tube digestif (GETAID). Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study. J Am Acad Dermatol. 2014 Jun;70(6):1146-9. doi: 10.1016/j.jaad.2014.03.005. PubMed PMID: 24831323. INFECTIEUXHubiche T, Schuffenecker I, Boralevi F, Léauté-Labrèze C, Bornebusch L, Chiaverini C, Phan A, Maruani A, Miquel J, Lafon ME, Lina B, Del Giudice P; Clinical Research Group of the French Society of Pediatric Dermatology Groupe de Recherche Clinique de la Société Française de Dermatologie Pédiatrique. Dermatological spectrum of hand, foot and mouth disease from classical to generalized exanthema. Pediatr Infect Dis J. 2014 Apr;33(4):e92-8. doi: 10.1097/INF.0000000000000120. PubMed PMID: 24463804. Duvignaud A, Receveur MC, Ezzedine K, Pistone T, Malvy D. Visceral leishmaniasis due to Leishmania infantum in a kidney transplant recipient living in France. Travel Med Infect Dis. 2014 Nov 21. pii: S1477-8939(14)00221-X. doi: 10.1016/j.tmaid.2014.11.007. [Epub ahead of print] PubMed PMID: 25487142. Malvy D, Khatibi S, Rivière B, Prudhomme L, Ezzedine K. Challenging issues and pitfalls for diagnosis of Human African trypanosomiasis in a Gabonese visitor, France. Travel Med Infect Dis. 2014 Oct 5;12(6PB):778-780. doi: 10.1016/j.tmaid.2014.09.010. [Epub ahead of print] PubMed PMID: 25453312. Pistone T, Ezzedine K, Duvignaud A, Mechain M, Receveur MC, Berry A, Malvy D. Q-10: L'émergence de Leishmania braziliensis en Guyane fait discuter l'adaptation de la prise en charge de la leishmaniose cutanée importée en Métropole. Med Mal Infect. 2014 Jun;44(6 Suppl):89. doi: 10.1016/S0399-077X(14)70315-4. French. PubMed PMID: 24994402. EPIDEMIOLOGIETouvier M, Deschasaux M, Montourcy M, Sutton A, Charnaux N, Kesse-Guyot E, Assmann KE, Fezeu L, Latino-Martel P, Druesne-Pecollo N, Guinot C, Latreille J, Malvy D, Galan P, Hercberg S, Le Clerc S, Souberbielle JC, Ezzedine K. Determinants of Vitamin D Status in Caucasian Adults: Influence of Sun Exposure, Dietary Intake, Sociodemographic, Lifestyle, Anthropometric, and Genetic Factors. J Invest Dermatol. 2014 Sep 11. doi: 10.1038/jid.2014.400. [Epub ahead of print] PubMed PMID: 25211176. Mahé A, Ezzedine K. Letter to the Editor concerning the article 'Geographical ancestry is a key determinant of epidermal morphology and dermal composition'. Br J Dermatol. 2014 Dec;171(6):1598-9. doi: 10.1111/bjd.13332. Epub 2014 Oct 30. PubMed PMID: 25142410. Touvier M, Deschasaux M, Montourcy M, Sutton A, Charnaux N, Kesse-Guyot E, Fezeu LK, Latino-Martel P, Druesne-Pecollo N, Malvy D, Galan P, Hercberg S, Ezzedine K, Souberbielle JC. Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values. J Clin Endocrinol Metab. 2014 Apr;99(4):1196-203. doi: 10.1210/jc.2013-3349. Epub 2014 Feb 14. PubMed PMID: 24527713. MELANOMEHu HH, Benfodda M, Dumaz N, Gazal S, Descamps V, Bourillon A, Basset-Seguin N, Riffault A, Ezzedine K, Bagot M, Bensussan A, Saiag P, Grandchamp B, Soufir N. A large french case-control study emphasizes the role of rare Mc1R variants in melanoma risk. Biomed Res Int. 2014;2014:925716. doi: 10.1155/2014/925716. Epub 2014 Apr 10. PubMed PMID: 24982914; PubMed Central PMCID: PMC4003837. Jouary T. [What's new in skin cancers?]. Ann Dermatol Venereol. 2014 Dec;141 Suppl 4:S630-42. doi: 10.1016/S0151-9638(14)70167-X. French. PubMed PMID: 25539755. Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Garbe C, Jouary T, Hauschild A, Grob JJ, Chiarion Sileni V, Lebbe C, Mandalà M, Millward M, Arance A, Bondarenko I, Haanen JB, Hansson J, Utikal J, Ferraresi V, Kovalenko N, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A, DeMarini DJ, Irani JG, Casey M, Ouellet D, Martin AM, Le N, Patel K, Flaherty K. Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma. N Engl J Med. 2014 Nov 13;371(20):1877-88. doi: 10.1056/NEJMoa1406037. Epub 2014 Sep 29. PubMed PMID: 25265492. Jouary T. [New lines of research in the treatment of melanoma]. Rev Prat. 2014 Jan;64(1):81-2. French. PubMed PMID: 24649553. Chaminade A, Conte H, Jouary T, Fauconneau A, Darrigade AS, Beylot-Barry M, Pham-Ledard A. BRAF inhibitors-induced panniculitis: a cutaneous side effect mimicking subcutaneous melanoma metastasis. J Eur Acad Dermatol Venereol. 2014 Feb 17. doi: 10.1111/jdv.12397. [Epub ahead of print] PubMed PMID: 24533578. Jdid R, Ezzedine K, Latreille J, Galan P, Hercberg S, Malvy D, Tschachler E, Guinot C. MC1R major variants are a risk factor of sleep lines in Caucasian women. J Eur Acad Dermatol Venereol. 2014 Jun;28(6):805-9. doi: 10.1111/jdv.12119. Epub 2013 Mar 4. PubMed PMID: 23452314. Leyvraz S, Piperno-Neumann S, Suciu S, Baurain JF, Zdzienicki M, Testori A, Marshall E, Scheulen M, Jouary T, Negrier S, Vermorken JB, Kaempgen E, Durando X, Schadendorf D, Gurunath RK, Keilholz U. Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial. Ann Oncol. 2014 Mar;25(3):742-6. doi: 10.1093/annonc/mdt585. Epub 2014 Feb 7. PubMed PMID: 24510314. McArthur GA, Chapman PB, Robert C, Larkin J, Haanen JB, Dummer R, Ribas A, Hogg D, Hamid O, Ascierto PA, Garbe C, Testori A, Maio M, Lorigan P, Lebbé C, Jouary T, Schadendorf D, O'Day SJ, Kirkwood JM, Eggermont AM, Dréno B, Sosman JA, Flaherty KT, Yin M, Caro I, Cheng S, Trunzer K, Hauschild A. Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study. Lancet Oncol. 2014 Mar;15(3):323-32. doi: 10.1016/S1470-2045(14)70012-9. Epub 2014 Feb 7. PubMed PMID: 24508103. Konstantinou MP, Dutriaux C, Gaudy-Marqueste C, Mortier L, Bedane C, Girard C, Thellier S, Jouary T, Grob JJ, Richard MA, Templier C, Sakji L, Guillot B, Paul C, Meyer N. Ipilimumab in melanoma patients with brain metastasis: a retro-spective multicentre evaluation of thirty-eight patients. Acta Derm Venereol. 2014 Jan;94(1):45-9. doi: 10.2340/00015555-1654. PubMed PMID: 23824275. Puntervoll HE, Yang XR, Vetti HH, Bachmann IM, Avril MF, Benfodda M, Catricalà C, Dalle S, Duval-Modeste AB, Ghiorzo P, Grammatico P, Harland M, Hayward NK, Hu HH, Jouary T, Martin-Denavit T, Ozola A, Palmer JM, Pastorino L, Pjanova D, Soufir N, Steine SJ, Stratigos AJ, Thomas L, Tinat J, Tsao H, Veinalde R, Tucker MA, Bressac-de Paillerets B, Newton-Bishop JA, Goldstein AM, Akslen LA, Molven A. Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. J Med Genet. 2013 Apr;50(4):264-70. doi: 10.1136/jmedgenet-2012-101455. Epub 2013 Feb 5. Erratum in: J Med Genet. 2014 Mar;51(3):214. PubMed PMID: 23384855; PubMed Central PMCID: PMC3607098. Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L, Hassel JC, Rutkowski P, McNeil C, Kalinka-Warzocha E, Savage KJ, Hernberg MM, Lebbé C, Charles J, Mihalcioiu C, Chiarion-Sileni V, Mauch C, Cognetti F, Arance A, Schmidt H, Schadendorf D, Gogas H, Lundgren-Eriksson L, Horak C, Sharkey B, Waxman IM, Atkinson V, Ascierto PA. Nivolumab in Previously Untreated Melanoma without BRAF Mutation. N Engl J Med. 2014 Nov 16. [Epub ahead of print] PubMed PMID: 25399552. Larkin J, Ascierto PA, Dréno B, Atkinson V, Liszkay G, Maio M, Mandalà M, Demidov L, Stroyakovskiy D, Thomas L, de la Cruz-Merino L, Dutriaux C, Garbe C, Sovak MA, Chang I, Choong N, Hack SP, McArthur GA, Ribas A. Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N Engl J Med. 2014 Nov 13;371(20):1867-76. doi: 10.1056/NEJMoa1408868. Epub 2014 Sep 29. PubMed PMID: 25265494. PEDIATRIECoughlin CC, Taïeb A. Evolving concepts of neonatal skin. Pediatr Dermatol. 2014 Nov;31 Suppl 1:5-8. doi: 10.1111/pde.12499. PubMed PMID: 25403932. Gey A, Ezzedine K, Diallo A, Prey S, Dreyfus I, Maza A, Mazereeuw-Hautier J, Taïeb A, Léauté-Labrèze C. Stay in NICU and infantile haemangioma development. J Eur Acad Dermatol Venereol. 2014 Aug 4. doi: 10.1111/jdv.12639. [Epub ahead of print] PubMed PMID: 25088718. Hérissé AL, Chiaverini C, Boralevi F, Maruani A, Phan A, Lacour JP; Société française de dermatologie pédiatrique. [Progressive pigmented purpuric dermatosis in young children]. Ann Dermatol Venereol. 2014 May;141(5):331-5. doi: 10.1016/j.annder.2014.01.018. Epub 2014 Mar 12. French. PubMed PMID: 24835645. Boralevi F, Diallo A, Miquel J, Guerin-Moreau M, Bessis D, Chiavérini C, Plantin P, Hubiche T, Maruani A, Lassalle M, Boursault L, Ezzedine K; Groupe de Recherche Clinique en Dermatologie Pédiatrique. Clinical phenotype of scabies by age. Pediatrics. 2014 Apr;133(4):e910-6. doi: 10.1542/peds.2013-2880. Epub 2014 Mar 31. PubMed PMID: 24685953. Boccara O, Méni C, Léauté-Labreze C, Bodemer C, Voisard JJ, Dufresne H, Brauchoux S, Taieb C. Haemangioma Family Burden: Creation of a Specific Questionnaire. Acta Derm Venereol. 2014 Mar 25. doi: 10.2340/00015555-1847. [Epub ahead of print] PubMed PMID: 24676555. GENODERMATOSE
Eytan O, Qiaoli L, Nousbeck J, van Steensel MA, Burger B, Hohl D, Taïeb A, Prey S, Bachmann D, Avitan-Hersh E, Jin Chung H, Shemer A, Trau H, Bergman R, Fuchs-Telem D, Warshauer E, Israeli S, Itin PH, Sarig O, Uitto J, Sprecher E. Increased epidermal expression and absence of mutations in CARD14 in a series of patients with sporadic pityriasis rubra pilaris. Br J Dermatol. 2014 May;170(5):1196-8. doi: 10.1111/bjd.12799. PubMed PMID: 24359224. Piard J, Aral B, Vabres P, Holder-Espinasse M, Mégarbané A, Gauthier S, Capra V, Pierquin G, Callier P, Baumann C, Pasquier L, Baujat G, Martorell L, Rodriguez A, Brady AF, Boralevi F, González-Enseñat MA, Rio M, Bodemer C, Philip N, Cordier MP, Goldenberg A, Demeer B, Wright M, Blair E, Puzenat E, Parent P, Sznajer Y, Francannet C, Didonato N, Boute O, Barlogis V, Moldovan O, Bessis D, Coubes C, Tardieu M, Cormier-Daire V, Sousa AB, Franques J, Toutain A, Tajir M, Elalaoui SC, Geneviève D, Thevenon J, Courcet JB, Rivière JB, Collet C, Gigot N, Faivre L, Thauvin-Robinet C. Search for ReCQL4 mutations in 39 patients genotyped for suspected Rothmund-Thomson/Baller-Gerold syndromes. Clin Genet. 2014 Feb 14. doi: 10.1111/cge.12361. [Epub ahead of print] PubMed PMID: 24635570. Chiaverini C, Charlesworth A, Fernandez A, Barbarot S, Bessis D, Bodemer C, Bursztejn AC, Cobo AM, Del Rio M, D'Incan M, Labrèze C, Langlet C, Mazereeuw J, Miquel J, Vabres P, Meneguzzi G, Lacour JP. Aplasia cutis congenita with dystrophic epidermolysis bullosa: clinical and mutational study. Br J Dermatol. 2014 Apr;170(4):901-6. doi: 10.1111/bjd.12741. PubMed PMID: 24252097. Dreyfus I, Pauwels C, Bourrat E, Bursztejn AC, Maruani A, Chiaverini C, Maza A, Mallet S, Bessis D, Barbarot S, Ezzedine K, Vabres P, Mazereeuw-Hautier J. Burden of Inherited Ichthyosis: A French National Survey. Acta Derm Venereol. 2014 Aug 27. doi: 10.2340/00015555-1955. [Epub ahead of print] PubMed PMID: 25510955. Frascari F, Dreyfus I, Rodriguez L, Gennero I, Ezzedine K, Salles JP, Mazereeuw-Hautier J. Prevalence and risk factors of vitamin D deficiency in inherited ichthyosis: a French prospective observational study performed in a reference center. Orphanet J Rare Dis. 2014 Aug 5;9:127. doi: 10.1186/s13023-014-0127-3. PubMed PMID: 25091406; PubMed Central PMCID: PMC4237956. Dreyfus I, Chouquet C, Ezzedine K, Henner S, Chiavérini C, Maza A, Pascal S, Rodriguez L, Vabres P, Martin L, Mallet S, Barbarot S, Dupuis J, Mazereeuw-Hautier J. Prevalence of inherited ichthyosis in France: a study using capture-recapture method. Orphanet J Rare Dis. 2014 Jan 6;9:1. doi: 10.1186/1750-1172-9-1. PubMed PMID: 24393603; PubMed Central PMCID: PMC3892037. Dreyfus I, Bourrat E, Maruani A, Bessis D, Chiavérini C, Vabres P, Ezzedine K, Mazereeuw-Hautier J. Factors associated with impaired quality of life in adult patients suffering from ichthyosis. Acta Derm Venereol. 2014 May;94(3):344-6. doi: 10.2340/00015555-1710. PubMed PMID: 24158261. van Steensel M, Vreeburg M, Urbina MT, López P, Morice-Picard F, van Geel M. Novel KRT83 and KRT86 mutations associated with monilethrix. Exp Dermatol. 2015 Jan 5. doi: 10.1111/exd.12624. [Epub ahead of print] PubMed PMID: 25557232. Morice-Picard F, Lasseaux E, Cailley D, Gros A, Toutain J, Plaisant C, Simon D, François S, Gilbert-Dussardier B, Kaplan J, Rooryck C, Lacombe D, Arveiler B. High-resolution array-CGH in patients with oculocutaneous albinism identifies new deletions of the TYR, OCA2, and SLC45A2 genes and a complex rearrangement of the OCA2 gene. Pigment Cell Melanoma Res. 2014 Jan;27(1):59-71. doi: 10.1111/pcmr.12173. Epub 2013 Oct 23. PubMed PMID: 24118800. Morice-Picard F, Lasseaux E, François S, Simon D, Rooryck C, Bieth E, Colin E, Bonneau D, Journel H, Walraedt S, Leroy BP, Meire F, Lacombe D, Arveiler B. SLC24A5 mutations are associated with non-syndromic oculocutaneous albinism. J Invest Dermatol. 2014 Feb;134(2):568-71. doi: 10.1038/jid.2013.360. Epub 2013 Aug 28. PubMed PMID: 23985994. INSERM U1035Dousset L, Seneschal J, Boniface K, Charreau S, Ezzedine K, Milpied B, Mossalayi MD, McGrath JA, Lecron JC, Taieb A. A Th2 Cytokine Interleukin 31 Signature in a Case of Sporadic Lichen Amyloidosis. Acta Derm Venereol. 2014 Feb 27. doi: 10.2340/00015555-1829. [Epub ahead of print] PubMed PMID: 24573820. Hosseini M, Mahfouf W, Serrano-Sanchez M, Raad H, Harfouche G, Bonneu M, Claverol S, Mazurier F, Rossignol R, Taieb A, Rezvani HR. Premature Skin Aging Features Rescued by Inhibition of NADPH Oxidase Activity in XPC-Deficient Mice. J Invest Dermatol. 2014 Dec 1. doi: 10.1038/jid.2014.511. [Epub ahead of print]PubMed PMID: 25437426. Hosseini M, Ezzedine K, Taieb A, Rezvani HR. Oxidative and Energy Metabolism as Potential Clues for Clinical Heterogeneity in Nucleotide Excision Repair Disorders. J Invest Dermatol. 2014 Oct 9. doi: 10.1038/jid.2014.365. [Epub ahead of print] Review. PubMed PMID: 25296907. Prey S, Leaute-Labreze C, Pain C, Moisan F, Vergnes P, Loot M, Taieb A, Cario-Andre M. Mast cells as possible targets of propranolol therapy: an gical study of beta-adrenergic receptors in infantile haemangiomas. Histopathology. 2014 Sep;65(3):436-9. doi: 10.1111/his.12421. Epub 2014 Jun 5. PubMed PMID: 24666350. Seneschal J, Jiang X, Kupper TS. Langerin+ dermal DC, but not Langerhans cells, are required for effective CD8-mediated immune responses after skin scarification with vaccinia virus. J Invest Dermatol. 2014 Mar;134(3):686-94. doi: 10.1038/jid.2013.418. Epub 2013 Oct 14. PubMed PMID: 24126845; PubMed Central PMCID: PMC3945525. Liu L, Rezvani HR, Back JH, Hosseini M, Tang X, Zhu Y, Mahfouf W, Raad H, Raji G, Athar M, Kim AL, Bickers DR. Inhibition of p38 MAPK signaling augments skin tumorigenesis via NOX2 driven ROS generation. PLoS One. 2014 May 13;9(5):e97245. doi: 10.1371/journal.pone.0097245. eCollection 2014. PubMed PMID: 24824222; PubMed Central PMCID: PMC4019556. Salducci M, André N, Guéré C, Martin M, Fitoussi R, Vié K, Cario-André M. Factors secreted by irradiated aged fibroblasts induce solar lentigo in pigmented reconstructed epidermis. Pigment Cell Melanoma Res. 2014 May;27(3):502-4. doi: 10.1111/pcmr.12234. Epub 2014 Mar 6. PubMed PMID: 24533682. |